In Situ Gel Delivery System of Methylprednisolone for Post Traumatic Spinal Injuries

Yan-Jun Che,Liang Chen,Guo-Hua Lv,Xiao-Bin Wang

DOI: https://doi.org/10.1166/jbt.2015.1347

2015-01-01

Journal of Biomaterials and Tissue Engineering

Abstract:Methylprednisolone is widely accepted as the first line drug in posttraumatic spinal cord injuries. But its i.v. administration is associated with various systemic adverse effects and it requires very high dosage in spinal cord injury. To overcome this limitation, in situ gels of methylprednisolone were prepared and evaluated. The prepared in situ gels were evaluated for visual appearance, clarity, pH, viscosity, in vitro drug release, in vivo anti inflammatory activity and motor function activity in spinal injury models (in rats). The physicochemical properties of the in situ gel were satisfactory. The gels of nnethylprednisolone showed good drug content (98.7 +/- 1.24 to 100.02 +/- 1.02%) and in vitro drug release (81.9 to 98.43% after 7 days). The in situ gel prepared from the 1% chitosan with 14% PLGA (IG3) showed the best in vivo anti-inflammatory activity (67.77% inhibition of paw edema in the standard carrageenan induced hind rat paw edema model). The gels were found to be very potential in the post traumatic induced spinal injury in rats. The improvement in motor activity (in horizontal bar) in spinal injury rat model was found to be maximum for IG3 which showed activity score of 4.80 +/- 0.09 at the end of 7 days against that of standard (4.42 +/- 0.22). Therefore, the prepared in situ gel of methylprednisolone may be used as a safer and effective alternative approach for drug delivery in the traumatic spinal cord injury.